Updated:
Keio Innovation Initiative
Keio Innovation Initiative is a Tokyo-based investment firm that focuses on investments in medical healthcare and technology-related companies. Founded in 2015.
Keio Innovation Initiative
Keio Innovation Initiative is a Tokyo-based investment firm that focuses on investments in medical healthcare and technology-related companies. Founded in 2015.
General information
Firm type
Venture Capital
Year founded
2015
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Principals
Kohei Itoh
President
Sector focus
Frequently asked questions
Who makes investment decisions at Keio Innovation Initiative?
Investment decisions are guided by the firm's leadership under Keio University President Kohei Itoh, though the specific investment committee structure and day-to-day deal leads are not publicly disclosed. The university's deep involvement suggests faculty input plays a role in technical diligence for science-heavy startups.
How does KII source its deal flow?
KII benefits from proprietary access to Keio University's research pipeline, including spinouts and licensing opportunities from its engineering, medical, and science faculties. This embedded position means many portfolio prospects reach the firm before circulating broadly among outside VCs.
Is Keio Innovation Initiative a single-family office or a venture capital firm?
KII is a venture capital firm, not a family office. It is wholly tied to Keio University, one of Japan's most prominent private universities, and operates as its technology commercialization arm rather than managing private family wealth.
What investment stages does KII target?
KII focuses on early-stage companies, including seed and start-up rounds, and makes selective expansion-stage investments. The firm's strategy prioritizes ventures that can leverage Keio's research infrastructure during the R&D-intensive phases of company building.
Which sectors define KII's portfolio?
KII targets deep-tech sectors aligned with Keio University's research strengths, including life sciences, robotics, advanced materials, AI and machine learning, and enterprise software. Its portfolio is shaped by the academic disciplines where Keio holds a competitive advantage.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: